{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:10:34Z","timestamp":1792599034627,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1136\/ard.2008.106021","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T00:13:56Z","timestamp":1244160836000},"page":"898-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis"],"prefix":"10.1016","volume":"69","author":[{"given":"Astrid","family":"J\u00fcngel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ospelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Sunyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat A","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate E","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Flory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Neidhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.106021_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2337","article-title":"Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts","volume":"9","author":"M\u00fcller-Ladner","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2008.106021_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/s10165-006-0490-6","article-title":"Cartilage destruction by matrix degradation products","volume":"16","author":"Yasuda","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard.2008.106021_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728222.7.1.19","article-title":"Metalloproteinases: their role in arthritis and potential as therapeutic targets","volume":"7","author":"Clark","year":"2003","journal-title":"Expert Opin Ther Targets"},{"key":"10.1136\/ard.2008.106021_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/ar2304","article-title":"Proteinases in the joint: clinical relevance of proteinases in joint destruction","volume":"9","author":"Rengel","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2008.106021_bib5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","article-title":"Biochemical characterization of human collagenase-3","volume":"271","author":"Kn\u00e4uper","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2008.106021_bib6","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/ar1873","article-title":"Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a neClinical and epidemiological research biglycan cleavage site","volume":"8","author":"Monfort","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2008.106021_bib7","doi-asserted-by":"crossref","first-page":"27781","DOI":"10.1074\/jbc.M703286200","article-title":"Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo Clinical and epidemiological researchithout joint fibroplasia side effects","volume":"282","author":"Johnson","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2008.106021_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.106021_bib9","first-page":"1607","article-title":"Synovial fibroblasts of patients Clinical and epidemiological researchith rheumatoid arthritis attach to and invade normal human cartilage Clinical and epidemiological researchhen engrafted into SCID mice","volume":"149","author":"M\u00fcller-Ladner","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.106021_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-4165(86)90306-5","article-title":"Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue","volume":"883","author":"Farndale Clinical and epidemiological research","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1136\/ard.2008.106021_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcdb.2007.06.006","article-title":"MMPs as therapeutic targets\u2014still a viable option?","volume":"19","author":"Fingleton","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"10.1136\/ard.2008.106021_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/ard.2007.076430","article-title":"Utility of animal models for identification of potential therapeutics for rheumatoid arthritis","volume":"67","author":"Hegen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.106021_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-003-0126-2","article-title":"The SCID mouse model: novel therapeutic targets - lessons from gene transfer","volume":"25","author":"Pierer","year":"2003","journal-title":"Springer Semin Immunopathol"},{"key":"10.1136\/ard.2008.106021_bib14","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/art.20186","article-title":"Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts","volume":"50","author":"Rutkauskaite","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.106021_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1172\/JCI118475","article-title":"Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage","volume":"97","author":"Mitchell","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2008.106021_bib16","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.11331","article-title":"Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation","volume":"48","author":"Fraser","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Pt 1","key":"10.1136\/ard.2008.106021_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/bj3310341","article-title":"Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression Clinical and epidemiological researchith collagenase-1 (matrix metalloproteinase-1)","volume":"331","author":"Vincenti","year":"1998","journal-title":"Biochem J"},{"key":"10.1136\/ard.2008.106021_bib18","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1074\/jbc.M007674200","article-title":"Identification and enzymatic characterization of tClinical and epidemiological researcho diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation","volume":"276","author":"Balb\u00edn","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.2008.106021_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2004.12.014","article-title":"Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840","volume":"508","author":"IshikaClinical and epidemiological researcha","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1136\/ard.2008.106021_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/s10165-004-0292-7","article-title":"Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3)","volume":"14","author":"Tardif","year":"2004","journal-title":"Mod Rheumatol"},{"key":"10.1136\/ard.2008.106021_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8","article-title":"Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest Clinical and epidemiological researchith a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)","volume":"43","author":"Dahlberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.106021_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/138161207779313551","article-title":"Matrix metalloproteinases as valid clinical targets","volume":"13","author":"Fingleton","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1136\/ard.2008.106021_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1749-6632.1999.tb07681.x","article-title":"Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin","volume":"878","author":"Beekman","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2008.106021_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138920108783497659","article-title":"Joint diseases and matrix metalloproteinases: a role for MMP-13","volume":"9","author":"Takaishi","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1136\/ard.2008.106021_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI10564","article-title":"Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice","volume":"107","author":"Neuhold","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2008.106021_bib26","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780400806","article-title":"Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium","volume":"40","author":"Lindy","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.106021_bib27","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/1529-0131(199907)42:7<1517::AID-ANR27>3.0.CO;2-G","article-title":"Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients Clinical and epidemiological researchith rheumatoid arthritis","volume":"42","author":"Clinical and epidemiological researchesthoff","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.106021_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0925-4439(00)00056-9","article-title":"Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts","volume":"1502","author":"Moore","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1136\/ard.2008.106021_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0945-053X(99)00030-X","article-title":"Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate","volume":"18","author":"Konttinen","year":"1999","journal-title":"Matrix Biol"},{"key":"10.1136\/ard.2008.106021_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/ard.61.5.391","article-title":"Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison Clinical and epidemiological researchith membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis","volume":"61","author":"PetroClinical and epidemiological research","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.106021_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01993304","article-title":"Synovial activation of chondrocytes: evidence for complex cytokine interactions","volume":"34","author":"Bandara","year":"1991","journal-title":"Agents Actions"},{"key":"10.1136\/ard.2008.106021_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-540-73259-4_5","article-title":"Anti-TNF antibodies: lessons from the past, roadmap for the future","volume":"181","author":"Shealy","year":"2008","journal-title":"Handb Exp Pharmacol"},{"key":"10.1136\/ard.2008.106021_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.2006.057497","article-title":"Radiological damage in patients Clinical and epidemiological researchith rheumatoid arthritis on sustained remission","volume":"66","author":"Cohen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.106021_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ncprheum0047","article-title":"Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis","volume":"1","author":"M\u00fcller-Ladner","year":"2005","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1136\/ard.2008.106021_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/14622416.8.7.761","article-title":"Pharmacogenetics of anti-TNF treatment in patients Clinical and epidemiological researchith rheumatoid arthritis","volume":"8","author":"Coenen","year":"2007","journal-title":"Pharmacogenomics"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724195295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724195295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.106021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:09:56Z","timestamp":1736086196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724195295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0003496724195295"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.106021","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.106021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}